Project Grant R01AR086795
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a Project Grant totaling $224,100 to the Regents of the University of California at Riverside under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award, effective September 15, 2025, through August 31, 2028, funds research to identify epigenetic factors controlling epidermal stem cell longevity in adult skin. The project addresses the...
- Federal Project Grant Award Summary Rockefeller University received a $100,228 Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded November 27, 2026, with completion expected by July 31, 2029. The project investigates embryonic hypoxia exposure as an epigenetic priming mechanism for postnatal epidermal response to inflammatory insult and wound healing....
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $524,335 Project Grant award dated June 5, 2026, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports basic research investigating the dynamic regulation of epidermal differentiation genes through cell-state-specific protein interactions of the PBAF chromatin...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded Icahn School of Medicine at Mount Sinai a $4.13 million Project Grant (CFDA 93.846, Arthritis, Musculoskeletal and Skin Diseases Research) effective September 1, 2025 through August 31, 2028. The research project, "Uncovering Novel Microbial Factors That Enhance Wound Repair," investigates the role of specific staphylococcal species and their toxins in...
- Federal Project Grant Award Summary The University of Chicago received a $451,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2030. This five-year award supports fundamental research investigating the metabolic control of extracellular matrix (ECM) synthesis, specifically examining how fibroblasts meet the metabolic demands required for...
- Federal Project Grant Award Summary New York University School of Medicine received a $148,062 Project Grant award effective September 30, 2025, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award funds basic research investigating the mechanisms of inflammatory memory in human epithelial cells, with completion targeted for May 31, 2028. The funded research will...
- Federal Grant Award Summary The University of Michigan received a $409,941 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 5, 2026, with completion targeted for December 31, 2030. This research initiative focuses on developing translational treatments for chronic wounds through cellular reprogramming strategies. The project addresses critical gaps in wound healing by...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded $368,156 to the University of California, Los Angeles under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) on June 5, 2026, with a completion date of May 31, 2028. The award supports the development and optimization of UGIGel, an innovative gelatin-based, self-healing bioadhesive engineered for chronic wound treatment. The product...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $483,286 Project Grant to Washington University (awarded July 6, 2026; completion June 30, 2031) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This research grant funds a comprehensive scientific investigation into the role of CD5+ dendritic cells in driving autoimmune skin inflammation, with particular application to psoriasis and...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $134,261 Project Grant award, effective September 1, 2025 through March 31, 2028, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The research focuses on genetic and genomic analysis of Electron Transport Chain (ETC) Complex II functions in mammalian skin development. The project...
The University of Chicago received a $1.57M Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), awarded July 15, 2026, with completion scheduled for June 30, 2030. The award funds research to decipher the immunomodulatory functions of epithelial stem cells during wound repair. The project addresses a critical knowledge gap regarding how epithelial stem cells located in the epidermis and hair follicles maintain self-renewal and differentiation capacity within inflammatory wound environments—a gap directly relevant to improving delayed or defective wound repair affecting aged and chronically ill populations at an estimated annual cost of $25B in U.S. healthcare expenditures. The research deliverables will elucidate mechanisms by which epithelial stem cells modulate their immunological niche to facilitate wound healing, building on preliminary findings indicating that hair follicle stem cells activate immune-modulatory capabilities such as CD80 expression to establish protective interactions with regulatory T cells. The project will investigate unconventional mechanisms for maintaining FOXP3 expression in wound-infiltrating effector T cells, with anticipated outputs advancing understanding of immune tolerance, barrier integrity, and wound repair biology applicable to therapeutic development.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.6m | 7/15/26 |